FVIII-independent FIX-mutant proteins for hemophilia A treatment

Details for Australian Patent Application No. 2008209986 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Dockal, Michael; Scheiflinger, Friedrich; Hartmann, Rudolf

Agent Cullen & Co

Pub. Number AU-A-2008209986

PCT Pub. Number WO2008/092644

Priority 60/898,877 01.02.07 US

Filing date 29 January 2008

Wipo publication date 7 August 2008

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/092644 Priority application(s): WO2008/092644

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209989-Process and plant for the production of an aqueous solution comprising urea

2008209985-Improved fix-mutant proteins for hemophilia B treatment